OraSure Technologies, Inc.

396 articles about OraSure Technologies, Inc.

• OraSure Technologies Appoints Lisa Nibauer as Infectious Disease Business Unit LeadBoard Change Also Announced

  5/5/2020

  OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced that Lisa Nibauer has been appointed Executive Vice President, Business Unit Leader, Infectious Disease.

• DNA Genotek’s ORAcollect®·RNA kit included in EUA granted to Biocerna SARS-CoV-2 test

  5/4/2020

  DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc., announced that its ORAcollect®·RNA kit was included as the collection device for anterior nares samples under a U.S.

• OraSure Technologies 2020 First Quarter Earnings Conference Call Invitation

  4/9/2020

  OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2020 first quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET on Wednesday, May 6, 2020..

• OraSure Technologies Appoints David J. Shulkin, M.D. to Board of DirectorsOther Board Changes Also Announced

  4/8/2020

  OraSure Technologies, Inc., a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced the appointment of David J. Shulkin, M.D., as a member of the Company’s Board of Directors.

• 

  Biopharma Update on the Novel Coronavirus: April 8

  4/8/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.

• OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test

  4/6/2020

  OraSure Technologies, Inc. announced it has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples.

• OraSure Technologies to Present at the Raymond James 41st Annual Institutional Investors Conference

  2/26/2020

  OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Raymond James 41st Annual Institutional Investors Conference.

• OraSure Announces 2019 Full Year and Fourth Quarter Financial Results

  2/19/2020

  OraSure Technologies, Inc. announced its financial results for the three months and year ended December 31, 2019.

• OraSure Technologies Earnings Conference Call Invitation2019 Fourth Quarter Earnings Conference Call Wednesday, February 19, 2020, 5:00 p.m. ET

  1/29/2020

  OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2019 fourth quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET on Wednesday, February 19, 2020..

• DNA Genotek Announces FDA General Use Clearance for Oragene®·Dx Family of Products

  1/22/2020

  DNA Genotek Inc. announced that the U.S. Food and Drug Administration has granted a general use 510 clearance for its Oragene®•Dx family of products.

• OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

  1/8/2020

  OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection devices, announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 38TH Annual J.P. Morgan Healthcare Conference.

• OraSure Technologies Announces 2020 Annual Meeting Date

  12/17/2019

  OraSure Technologies, Inc. announced that its 2020 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT on Tuesday, May 19, 2020.

• OraSure Technologies, Inc. Announces Purchase of DiversigenAcquisition extends OraSure’s leadership position in the microbiome services industry

  11/6/2019

  OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into a definitive agreement to acquire the outstanding equity of Diversigen in an all-cash transaction.

• OraSure Technologies to Present at Stephens 2019 Nashville Investment Conference

  11/6/2019

  OraSure Technologies, Inc. announced that Dr. Stephen S. Tang, President and CEO, and Mr. Roberto Cuca, Chief Financial Officer will host a fireside chat with the investment community at the Stephens 2019 Nashville Investment Conference.

• OraSure Announces 2019 Third Quarter Financial Results

  11/6/2019

  OraSure Technologies, Inc., a leader in point-of-care diagnostic tests and specimen collection devices, announced its financial results for the three and nine months ended September 30, 2019.

• OraSure Technologies Earnings Conference Call Invitation2019 Third Quarter Earnings Conference Call Wednesday, November 6, 2019, 5:00 p.m. ET

  10/22/2019

  OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2019 third quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET on Wednesday, November 6, 2019..

• CoreBiome Announces Leading Microbiome Researcher Rob Knight as Scientific Advisor

  4/25/2019

  CoreBiom announced that Rob Knight, Professor and Director of the Center for Microbiome Innovation at the University of California San Diego, has joined its scientific advisory board.

• OraSure Technologies Earnings Conference Call Invitation 2018 Third Quarter Earnings Conference Call Wednesday, November 7, 2018, 5:00 p.m. ET

  10/8/2018

  OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2018 third quarter financial results, 2018 fourth quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 7, 2018. 

• 

  BioSpace Movers and Shakers Sept. 24

  9/24/2018

  Here's a look at who's making moves in the biotech and pharma world this week.

• OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results

  2/8/2018

  Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016.